# Rhenman & Partners Asset Management 13F Q2 2026

Rhenman & Partners Asset Management AB reported $1.1 billion in 13F securities across 99 positions for the quarter ended June 30, 2026, in a holdings report filed August 13, 2026. Its largest holding was Unitedhealth Group Inc at $38.9 million, 3.7% of the reported value. Since Q1 2026 it opened 21 new positions and exited 8.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,059,428,235
- Positions: 99
- Filed: August 13, 2026
- Report type: 13F holdings report
- CIK: 1599882
- Form 13F file number: 028-15944
- Business address: Strandvagen 5a, Stockholm, 11451 Sweden
- SEC filing: [0001213900-26-088652](https://www.sec.gov/Archives/edgar/data/1599882/000121390026088652/0001213900-26-088652-index.htm)

## Top 25 holdings by value

The largest of 99 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 93,600 | $38.9 million | +48,100 |
| [CVS Health Corp](https://specstream.ai/data/institutional-holders/cvs-health-corp-126650100) | COM | 279,374 | $28.9 million | -57,126 |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 151,500 | $28.5 million | New |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 213,500 | $27.4 million | New |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 22,315 | $26.8 million | -11,400 |
| [Abbvie Inc](https://specstream.ai/data/institutional-holders/abbvie-inc-00287y109) | COM | 96,775 | $24.4 million | +25,200 |
| [Alignment Healthcare Inc](https://specstream.ai/data/institutional-holders/alignment-healthcare-inc-01625v104) | COM | 997,083 | $23.7 million | -56,367 |
| [Edwards Lifesciences Corp](https://specstream.ai/data/institutional-holders/edwards-lifesciences-corp-28176e108) | COM | 260,000 | $23.5 million | +97,000 |
| [Gilead Sciences Inc](https://specstream.ai/data/institutional-holders/gilead-sciences-inc-375558103) | COM | 178,250 | $22.5 million | +10,500 |
| [Jazz Pharmaceuticals PLC](https://specstream.ai/data/institutional-holders/jazz-pharmaceuticals-plc-g50871105) | SHS USD | 87,440 | $21.1 million | +11,550 |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 94,850 | $20.5 million | -14,250 |
| [Stryker Corporation](https://specstream.ai/data/institutional-holders/stryker-corporation-863667101) | COM | 65,000 | $20.5 million | +17,200 |
| [Boston Scientific Corp](https://specstream.ai/data/institutional-holders/boston-scientific-corp-101137107) | COM | 450,500 | $19.2 million | -174,500 |
| [Johnson & Johnson](https://specstream.ai/data/institutional-holders/johnson-johnson-478160104) | COM | 72,500 | $18.4 million | New |
| [Guardant Health Inc](https://specstream.ai/data/institutional-holders/guardant-health-inc-40131m109) | COM | 115,000 | $17.3 million | -30,000 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 27,390 | $17.1 million | -20,710 |
| [Glaukos Corp](https://specstream.ai/data/institutional-holders/glaukos-corp-377322102) | COM | 119,000 | $16.6 million | +35,000 |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 290,500 | $16.6 million | +83,500 |
| [Nurix Therapeutics Inc](https://specstream.ai/data/institutional-holders/nurix-therapeutics-inc-67080m103) | COM | 684,250 | $16.6 million | +370,750 |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 61,050 | $16.6 million | +9,450 |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 139,205 | $16.3 million | +46,600 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 151,960 | $16.2 million | -7,800 |
| [Tenet Healthcare Corp](https://specstream.ai/data/institutional-holders/tenet-healthcare-corp-88033g407) | COM NEW | 85,200 | $15.9 million | +31,200 |
| [Thermo Fisher Scientific Inc](https://specstream.ai/data/institutional-holders/thermo-fisher-scientific-inc-883556102) | COM | 31,580 | $15.8 million | -9,760 |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 244,000 | $15.7 million | New |

## New positions in Q2 2026

21 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Astrazeneca PLC](https://specstream.ai/data/institutional-holders/astrazeneca-plc-g0593m107) | ORD | 151,500 | $28.5 million |
| [Merck & Co Inc](https://specstream.ai/data/institutional-holders/merck-co-inc-58933y105) | COM | 213,500 | $27.4 million |
| [Johnson & Johnson](https://specstream.ai/data/institutional-holders/johnson-johnson-478160104) | COM | 72,500 | $18.4 million |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 244,000 | $15.7 million |
| [Dexcom Inc](https://specstream.ai/data/institutional-holders/dexcom-inc-252131107) | COM | 160,000 | $10.8 million |
| [Spyre Therapeutics Inc](https://specstream.ai/data/institutional-holders/spyre-therapeutics-inc-00773j202) | COM NEW | 119,300 | $10.6 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 80,000 | $7.6 million |
| [Erasca Inc](https://specstream.ai/data/institutional-holders/erasca-inc-29479a108) | COM | 349,000 | $6.4 million |
| [Astrana Health Inc](https://specstream.ai/data/institutional-holders/astrana-health-inc-03763a207) | COM NEW | 118,888 | $5.5 million |
| [Molina Healthcare Inc](https://specstream.ai/data/institutional-holders/molina-healthcare-inc-60855r100) | COM | 21,857 | $5 million |
| [Amn Healthcare SVCS Inc](https://specstream.ai/data/institutional-holders/amn-healthcare-svcs-inc-001744101) | COM | 144,466 | $4.7 million |
| [Medpace Hldgs Inc](https://specstream.ai/data/institutional-holders/medpace-hldgs-inc-58506q109) | COM | 8,500 | $4.5 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 15,000 | $4 million |
| [MBX Biosciences Inc](https://specstream.ai/data/institutional-holders/mbx-biosciences-inc-55287l101) | COM | 62,000 | $3.4 million |
| [Bicara Therapeutics Inc](https://specstream.ai/data/institutional-holders/bicara-therapeutics-inc-055477103) | COM | 88,150 | $2.6 million |
| [Privia Health Group Inc](https://specstream.ai/data/institutional-holders/privia-health-group-inc-74276r102) | COM | 50,000 | $1.3 million |
| [Minimed Group Inc](https://specstream.ai/data/institutional-holders/minimed-group-inc-60365f109) | COM | 55,000 | $822,250 |
| [Agilon Health Inc](https://specstream.ai/data/institutional-holders/agilon-health-inc-00857u206) | COM NEW | 5,000 | $535,900 |
| [10x Genomics Inc](https://specstream.ai/data/institutional-holders/10x-genomics-inc-88025u109) | CL A COM | 8,500 | $325,890 |
| [Tandem Diabetes Care Inc](https://specstream.ai/data/institutional-holders/tandem-diabetes-care-inc-875372203) | COM NEW | 20,000 | $301,800 |
| [TG Therapeutics Inc](https://specstream.ai/data/institutional-holders/tg-therapeutics-inc-88322q108) | COM | 5,000 | $274,700 |

## Positions exited in Q2 2026

8 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Adaptive Biotechnologies Cor](https://specstream.ai/data/institutional-holders/adaptive-biotechnologies-cor-00650f109) | COM | 720,000 | $10 million |
| [Iqvia Hldgs Inc](https://specstream.ai/data/institutional-holders/iqvia-hldgs-inc-46266c105) | COM | 53,000 | $9 million |
| [Nuvalent Inc](https://specstream.ai/data/institutional-holders/nuvalent-inc-670703107) | COM | 81,200 | $8.3 million |
| [Apogee Therapeutics Inc](https://specstream.ai/data/institutional-holders/apogee-therapeutics-inc-03770n101) | COM | 75,000 | $6.3 million |
| Ascendis Pharma A/S | SPONSORED ADR | 15,000 | $3.4 million |
| [Esperion Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/esperion-therapeutics-inc-ne-29664w105) | COM | 985,000 | $2.7 million |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 85,724 | $2.6 million |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 115,113 | $608,948 |

## Also on SpecStream

- [Rhenman & Partners Asset Management AB Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1599882/000121390026088652/0001213900-26-088652-index.htm)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Fence contractors in the United States](https://specstream.ai/data/businesses/fence-contractors/united-states)
- [Waste collection companies in the United States](https://specstream.ai/data/businesses/waste-collection-companies/united-states)
- [Lawn care companies in the United States](https://specstream.ai/data/businesses/lawn-care-companies/united-states)
- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
- [Private investigators in the United States](https://specstream.ai/data/businesses/private-investigators/united-states)
